Lower Trapezius Transfer Maintains Meaningful Outcomes at 5 Years Based on Procedure‐Specific Minimal Clinically Important Difference and Patient Acceptable Symptom State Achievement
- 21 June 2026
- journal article
- Published by Wiley in Arthroscopy
- Vol. 42 (10) , 1946-1954
Abstract
Purpose: To quantify patient‐reported outcomes at 5 years after arthroscopic‐assisted lower trapezius tendon transfer irreparable posterosuperior rotator cuff tears and to establish procedure‐specific minimal clinically important difference (MCID) and patient acceptable symptom state (PASS) thresholds. Methods: From 2017 to 2019, we retrospectively reviewed consecutive lower trapezius tendon transfer cases for irreparable posterosuperior tears with a minimum 5‐year follow‐up. Patient‐reported outcome measures (PROMs) (American Shoulder and Elbow Surgeons [ASES] score, Constant‐Murley, Activities of Daily Living and External Rotation [ADLER] score, visual analog pain scale [VAS]) were collected pre‐ and postoperatively. MCIDs were calculated by a distribution‐based approach (.5 SD), and PASS thresholds were derived by receiver operating characteristic‐Youden for PROMs with acceptable discrimination (area under the curve (AUC) > .70). Associations of age, sex, body mass index, diabetes, hypertension, and teres‐minor trophicity with MCID/PASS attainment were evaluated. Results: We analyzed 34 shoulders (23 men/11 women; mean age 63.5 ± 5.5 years) at a mean 76.5 ± 5.7 months (range, 65‐89). MCID thresholds were ASES 8.2 (79.4%), Constant 7.4 (70.6%), ADLER 3.0 (76.5%), and VAS 3.0 (70.6%). AUC values were as follows: ASES .97 (95% CI, .92‐1.00), Constant .72 (.48‐.91), ADLER .74 (.54‐.91), and VAS .70 (.54‐.92). PASS thresholds were ASES ≥ 83 (61.8%), Constant ≥ 73 (41.2%), and ADLER ≥ 28 (61.8%); VAS showed borderline discrimination and was not retained for PASS reporting. Higher teres minor trophicity correlated with ADLER MCID ( ρ = −.743, P < −.001) and PASS ( ρ = −.649, P < −.001). Younger age correlated with ASES PASS ( ρ = −.427, P = .012) and Constant PASS ( ρ = −.504, P = .002). Sex and comorbidities were not associated. Conclusions: Arthroscopic‐assisted lower trapezius tendon transfer yielded durable, clinically meaningful improvement at least 5 years, and procedure‐specific MCID and PASS thresholds were established for ASES, Constant‐Murley, and ADLER. Preoperative trophicity of the teres minor was a significant predictor of PASS achievement. Level of Evidence: Level IV, therapeutic retrospective cohort study.Keywords
This publication has 49 references indexed in Scilit:
- Arthroscopic Lower Trapezius Tendon Transfer Effectively Relieves Pain and Improves Shoulder Function in Patients With Irreparable Infraspinatus Tears: Minimum 5‐Year Follow‐UpArthroscopy, 2025
- Determining patient acceptable symptom states from patient reported outcome measures following reverse shoulder arthroplasty: Constant-murley, UCLA, Oxford Shoulder ScoresJournal of Orthopaedics, 2024
- Lower Trapezius Transfer Improves Clinical Outcomes With a Rate of Complications and Reoperations Comparable to Other Surgical Alternatives in Patients with Functionally Irreparable Rotator Cuff Tears: A Systematic ReviewArthroscopy, 2023
- Lower trapezius transfer for massive posterosuperior rotator cuff defectsOperative Orthopädie und Traumatologie, 2021
- Short‐Term Outcomes of Lower Trapezius Tendon Transfer With Achilles Allograft for Irreparable Posterosuperior Rotator Cuff TearsArthroscopy, Sports Medicine, and Rehabilitation, 2020
- Lower trapezius transfer with semitendinosus tendon augmentationObere Extremität, 2018
- Lower trapezius transfer with Achilles tendon augmentation: indication and clinical resultsObere Extremität, 2018
- Massive irreparable rotator cuff tearsObere Extremität, 2018
- The Role of Tendon Transfers for Irreparable Rotator Cuff TearsCurrent Reviews in Musculoskeletal Medicine, 2018
- Modified L'Episcopo Tendon Transfers for Irreparable Rotator Cuff Tears: 5-year FollowupClinical Orthopaedics and Related Research, 2010